Pricing Log in Create free account

Innate Pharma S.A. Sponsored ADR (IPHA) vs Whitehawk Therapeutics, Inc. (WHWK)

Innate Pharma S.A. Sponsored ADR and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Innate Pharma S.A. Sponsored ADR and Whitehawk Therapeutics, Inc. are of similar size ($173.3M and $165.3M). Whitehawk Therapeutics, Inc. grew revenue faster over the last twelve months: 16.5% against −4.17%. Whitehawk Therapeutics, Inc. has the higher net margin (0.00% vs −99.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Whitehawk Therapeutics, Inc. leads on 7 and Innate Pharma S.A. Sponsored ADR on 6.

Valuation

Metric IPHA WHWK Biotechnology median
P/E n/m n/m 8.50
P/S n/m 8.65 9.71
P/B n/m 1.31 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.12 1.85 9.21
Earnings yield (81.58%) (38.62%) (33.15%)
Free cash flow yield 0.00% (29.08%) (25.50%)

Profitability

Metric IPHA WHWK Biotechnology median
Gross margin 0.00% 88.72% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (99.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (44.98%) (56.36%)
Return on assets 0.00% (42.60%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IPHA WHWK Biotechnology median
Revenue growth (TTM) (4.17%) 16.51% 6.02%
EPS growth (last fiscal year) 6.06% 86.02% 30.26%
Revenue growth, 5-year CAGR (33.86%) (13.29%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IPHA WHWK Biotechnology median
Debt to equity (0.50) 0.00 0.00
Current ratio 0.60 17.38 4.72
Net debt to EBITDA 0.22 1.26 0.96

Dividend

Metric IPHA WHWK Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IPHA WHWK Biotechnology median
Market cap 165.32m 173.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack